Transferência deferida
#25.1
05/14/2024
RPI 2784
Application data
Number
112020007359Type
Filing
Publication
PCT
EP2018000470 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 05/14/2024. We update with every new RPI gazette, published weekly.
Applicants
A. T. (pessoa física)
ES
ESTEVE PHARMACEUTICALS, S.A.
ES
Inventors
C. A. (pessoa física)
ES
N. T. (pessoa física)
ES
IPC Classification
Priority claims
EP
17 382 695.9 · 10/17/2017
Abstract
A presente invenção refere-se aos sais de (R)-9-(2,5-difluorofenetil)-4-etil-2-metil-1-oxa-4,9-diazaespiro[5.5] undecan-3-ona, a composições farmacêuticas compreendendo-os, e ao seu uso em terapia e/ou profilaxia de doenças associadas com receptor sigma e/ou receptor µ-opioide.
Publications in the Brazilian Industrial Property Gazette (RPI).
#25.1
05/14/2024
RPI 2784
#6.23
08/23/2022
RPI 2694
#15.35
11/23/2021
RPI 2655
#1.3
09/29/2020
RPI 2595
#1.1
09/08/2020
RPI 2592
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.